Delivery Order SPE2DB22D1017-SPE2DB24FF3NC
- Not listed
- This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $34,531.92, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Rinvoq ER 15 MG tablets. The contract has a ceiling value of $12,930.51 and is a delivery order with a firm fixed price. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of Rinvoq ER 45 mg tablets to the Defense Logistics Agency (DLA). The $29,975.83 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The award has an ultimate completion date of October 30, 2023 and was not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $13,155.21 and a period of performance through January 29, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,491.18, is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which does business as...
- This federal contract award is for the delivery of the pharmaceutical product Rinvoq ER 15 MG Tablet UU 30S, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a total ceiling value of $36,397.91 and an ultimate completion date of December 4, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is an experienced pharmaceutical distributor that...
- This contract award is for the delivery of Rinvoq ER 45 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $7,986.69 and a period of performance through February 8, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract was not set aside for any specific business category. Amerisourcebergen Drug...
- The federal contract award is for delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $27,495.84 firm fixed price delivery order has a completion date of January 29, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as a primary vehicle for delivering a...
- This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The contract, valued at $79,141.34, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor and healthcare...
- This federal contract award is for the delivery of a specific pharmaceutical product, Rinvoq ER 15 mg tablets, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,585.33 and a completion date of September 1, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF3NCDelivery Order
This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $24,780.28, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is March 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which enables efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.8k | 2/29/24 |